Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dry powder inhaler formulation.

Martin J Telko1, Anthony J Hickey

  • 1School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, USA.

Respiratory Care
|August 27, 2005
PubMed
Summary

Dry powder inhaler (DPI) formulations require careful design of drug blends and devices for effective lung delivery. Understanding powder properties and airflow dynamics is key to optimizing drug deposition and therapeutic performance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dose optimization of inhaled tigecycline in humans to overcome inherent adverse events and maximize bacterial clearance using a physiologically-based pharmacokinetic modeling approach.

Frontiers in tuberculosis·2026
Same author

Effect of biofilm formation on the antimicrobial activity of tigecycline against <i>Mycobacterium abscessus</i> in the hollow fiber infection model.

Frontiers in microbiology·2026
Same author

Outstanding Contributions to Aerosol Pulmonary Drug Delivery.

Kona : powder science and technology in Japan·2026
Same author

Pharmacokinetics and Physiologically Based Pharmacokinetic Modeling of Mycobacteriophages: Insights into Pulmonary Distribution and Clearance.

bioRxiv : the preprint server for biology·2026
Same author

<i>In vitro</i> PK/PD modeling and simulation to accurately assess the antimicrobial activity of tigecycline against <i>Mycobacterium abscessus</i>.

Antimicrobial agents and chemotherapy·2025
Same author

2025 Top JPharmSci Reviewers.

Journal of pharmaceutical sciences·2025

Area of Science:

  • Pharmaceutical Sciences
  • Materials Science
  • Aerosol Science

Background:

  • Drug products require specific pharmaceutical properties for effective delivery.
  • Dry powder inhalers (DPIs) aim for stable, reproducible drug delivery to target organs.
  • DPI performance depends on formulation, metering, and device selection.

Purpose of the Study:

  • To review the formulation and development process of dry powder inhalers (DPIs).
  • To highlight the critical role of powder properties and aerodynamic behavior in DPI performance.
  • To discuss the scientific underpinnings of DPI formulation development.

Main Methods:

  • Review of DPI formulation strategies, focusing on drug-carrier blends.
  • Analysis of physicochemical properties influencing powder flow, dispersion, and aerodynamic behavior.
  • Examination of the interplay between formulation, actuation, airflow, and lung deposition.

Main Results:

  • Most DPI formulations use micronized drug blended with larger carrier particles to improve flow and dispersion.
  • Particle properties (size, shape, surface area, morphology) significantly impact drug delivery efficiency.
  • Inadequate drug-carrier separation due to strong cohesive forces leads to low deposition.

Conclusions:

  • Optimizing DPI performance relies on a synergistic approach involving formulation science, aerosol physics, and solid-state chemistry.
  • Advances in fundamental science are transitioning DPI development from empirical methods to a more robust scientific foundation.
  • Effective DPI design necessitates a deep understanding of powder-fluid interactions for efficient drug aerosolization and lung deposition.

Related Experiment Videos